Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy. - Xu C; Yan T; Wen S; Wu C; Chang T; Kong E; Liu H (BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2026)